Role of Operative Therapy in Non-cirrhotic Patients with Metastatic Hepatocellular Carcinoma

Journal of Gastrointestinal Surgery, 06/12/2012

Resection and ablation are associated with an improved progression–free survival (PFS) and long–term overall survival (OS) and should be considered in select patients with metastatic hepatocellular carcinoma (HCC).

Print Article Summary Cat 2 CME Report